CEO interview from DNB North American Life Science Conference

10. Jan 2020 | 0 min read

CEO interview from DNB North American Life Science Conference

Gentian’s CEO Dr Hilja Ibert was interviewed at DNB North American Life Science Conference in December 2019. In this interview she talks about Gentian as a company working towards diagnostic efficiency, our immunoassays and the outlook for 2020.

See the whole interview here.

You may also read


#FAQ: Avian antibodies – Immunoglobulin Y(IgY)

Jan 23, 2020

#FAQ: Avian antibodies – Immunoglobulin Y(IgY)

Avian antibodies in our commercial products since 2005 Gentian has applied avian antibodies with great..

CEO Interview at Arctic Securities

Jan 17, 2020

CEO Interview at Arctic Securities

Our CEO Dr. Hilja Ibert recently sat down with Pål Falck in Arctic Securities to have a look at Gentian's..

Diagnostic Efficiency by Gentian - Newsletter H1-2020

Jan 14, 2020

Diagnostic Efficiency by Gentian - Newsletter H1-2020

  Happy New Year 2020 We look forward to exhibiting at and visiting numerous trade shows and congresses..